Skip to content
You can now search across every topic, entity and event.What's new
UK Startups and Innovation
22APR

FCA names eight firms in AI Live Testing round two

3 min read
17:16UTC

Two startups, five incumbents, one Swiss bank, and one technical partner: the FCA's AI sandbox is starting to look like institutional infrastructure rather than a pilot.

TechnologyDeveloping
Key takeaway

FCA sandbox demand has surged and AI assurance methodology is crystallising around a single London vendor.

The Financial Conduct Authority (FCA) named its second AI Live Testing cohort on 21 April 2026: Aereve, Coadjute, Barclays, Experian, GoCardless, Lloyds Banking Group via Scottish Widows, UBS, and Palindrome. London AI-assurance startup Advai joined as technical partner, providing the cohort's evaluation methodology. Cohort evaluation lands in Q1 2027.

AI Live Testing sits inside the broader FCA Regulatory Sandbox, the programme that lets authorised firms test products in live market conditions under conditional permissions. Applications to the wider sandbox are up 49% year on year, the highest volume since the Innovation Hub launched in 2016. The cohort mix is deliberately bimodal: incumbent banks (Barclays, Lloyds, UBS) are testing AI against the same framework as challenger and startup firms (Aereve, Coadjute, Palindrome), with Advai's assurance methodology applied across both tiers. The regulator wants a single evidence base covering customer-risk AI models at both incumbent and challenger scale.

The composition reveals the sandbox's new centre of gravity. Experian brings credit-scoring models; GoCardless brings payment-fraud detection; the Lloyds/Scottish Widows participation targets life and pensions AI; UBS brings wealth-management use cases. Advai is the only dedicated AI-assurance vendor in the picture, which means its methodology will set the de facto evaluation standard for the cohort's output.

Innovate UK's shift to a DARPA-style portfolio model and the FCA's AI Live Testing expansion are parallel moves toward active programme management rather than passive competition windows. For UK fintech founders, the Q1 2027 evaluation is the date to track; the results will either unlock a faster authorisation path for AI in regulated finance or expose the structural gap between what the regulator can assess and what firms are actually shipping.

Deep Analysis

In plain English

The FCA (Financial Conduct Authority) is the UK body that regulates banks and financial companies. It runs a programme where it lets companies test new AI tools inside a controlled environment, with special regulatory permissions, before allowing them into the full market. This week it named eight organisations for its second batch of companies going through that process; a mix of big banks like Barclays and Lloyds, and smaller tech firms. The 49% jump in applications to join the programme suggests a lot more financial companies are building AI products and want regulatory approval to use them.

Deep Analysis
Root Causes

The EU AI Act's financial services provisions, which came into force in stages from August 2024, created a regulatory divergence that UK-authorised firms must navigate: EU-passported services now require AI system classification under EUAIA rules, while UK-only activities face a principles-based FCA framework without equivalent statutory classification requirements. The FCA AI Live Testing programme is the UK's pre-statutory response; building an evidence base before legislation is necessary.

Advai's selection as technical partner; rather than an established firm like Accenture or PwC; reflects the FCA's intent to validate a startup-led AI assurance market; if Advai's methodology is endorsed by the FCA's Q1 2027 evaluation report, it becomes a de facto standard that fintech founders must reference in their own AI governance documentation.

What could happen next?
  • Consequence

    Advai's endorsement as FCA technical partner will generate commercial demand for its AI assurance methodology from all firms seeking FCA AI-related authorisation after Q1 2027, regardless of whether they were in the cohort; expect Advai to raise a Series A within 12 months of the evaluation report's publication.

  • Risk

    If the FCA's Q1 2027 'good and poor practice' report finds that incumbent-bank AI deployments outperform startup ones on safety metrics, it will create a precedential bias in FCA authorisation decisions that disadvantages fintech challengers in AI-enabled credit and payments applications.

First Reported In

Update #2 · Britain's innovation pipe leaks at both ends

CNBC· 22 Apr 2026
Read original
Causes and effects
This Event
FCA names eight firms in AI Live Testing round two
FCA Regulatory Sandbox applications are up 49% year on year, the clearest regulator-side signal yet that UK fintech formation is running hot into Q2 2026.
Different Perspectives
Institute of Physics
Institute of Physics
The Institute has long argued STFC's national-laboratory infrastructure, not its grant programmes, is the binding constraint on UK physics output, and warns mothballing capacity like Clara removes capability that cannot be rebuilt on a four-year cycle. It represents the discovery-science community absorbing the reallocation the Bank's equity cheques do not touch.
Helsing
Helsing
The Munich-headquartered defence-AI firm chose Plymouth over Continental sites for a £350m manufacturing plant building underwater surveillance gliders, alongside its record raise. Its choice of postcode signals confidence in UK manufacturing capacity for defence hardware even as it looks abroad for the capital financing that hardware.
Dragoneer Investment Group, Lightspeed Venture Partners and Iconiq
Dragoneer Investment Group, Lightspeed Venture Partners and Iconiq
The three US growth-capital firms backed Helsing's $1.8bn round at an $18bn valuation, more than doubling the mark set only a year earlier, with demand reportedly exceeding the capital on offer. Their money, not a UK sovereign vehicle, is what funds the Plymouth plant, extending a pattern of foreign capital underwriting British defence-hardware manufacturing this cycle.
British Business Bank
British Business Bank
The Bank wrote its largest-ever direct life-sciences cheque into Alchemab and added a £6.5bn SME lending guarantee the same week UKRI confirmed the STFC cuts. It is deploying an April mandate change letting it lead venture rounds and invest directly up to £60m per company, treating equity extension rounds and small-business debt as newly within its risk appetite.
Daphni
Daphni
The Paris seed fund joined Speedinvest and three UK backers in Astral Systems' GBP23m Series A for modular fusion reactors, one of the round's five European co-investors betting on lab-to-market fusion ahead of any working commercial reactor. Unlike CuspAI's all-foreign cap table, this round kept a UK lead investor in Mercia Ventures.
EQT
EQT
EQT, appointed by the European Innovation Council to run the EUR5bn Scaleup Europe Fund, entered advanced talks for a further CuspAI stake reported on 3 July, the fund's first pursuit of a UK-founded winner. A closed deal would put EU sovereign capital, not a UK vehicle, on the cap table of a company Britain's own funds passed over.